(19)
(11)
EP 1 309 686 A2
(12)
(88)
Date of publication A3:
22.08.2002
(43)
Date of publication:
14.05.2003
Bulletin 2003/20
(21)
Application number:
01952313.3
(22)
Date of filing:
29.06.2001
(51)
International Patent Classification (IPC)
7
:
C12N
15/12
,
C12N
15/62
,
C12N
15/63
,
C12N
15/11
,
C12N
1/21
,
C12N
5/10
,
G01N
33/68
,
C12Q
1/68
,
C07K
14/705
,
C07K
16/28
,
A61K
38/17
,
A61K
39/395
,
A61K
48/00
,
A61K
31/7088
,
A61K
31/713
(86)
International application number:
PCT/US0120/751
(87)
International publication number:
WO 0200/2602
(
10.01.2002
Gazette 2002/02)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
30.06.2000
US 608921
(71)
Applicant:
Millennium Pharmaceuticals, Inc.
Cambridge,Massachusetts 02139 (US)
(72)
Inventor:
TSAI, Fong-Ying
Newton, MA 02168 (US)
(74)
Representative:
Hall, Robert Leonard et al
Harrison Goddard Foote,Fountain Precinct,Leopold Street
Sheffield S1 2QD
Sheffield S1 2QD (GB)
(54)
SLGP PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR